NEC Acquires Norwegian Bioinformatics Company, OncoImmunity AS

Jul 29, 2019 17:49 JST

Source: NEC Corporation

TOKYO, Jul 29, 2019 - (JCN Newswire) - NEC Corporation (TSE: 6701) has announced the acquisition of OncoImmunity AS, a Norway-based bioinformatics company that develops proprietary machine learning software to support the fight against cancer. OncoImmunity AS will now become a subsidiary of NEC and operate under the name of NEC OncoImmunity AS.

OncoImmunity AS, founded in 2014, is a bioinformatics company dedicated to the development of software solutions that facilitate the effective selection of patients for cancer immunotherapy, and identify optimal neoantigen targets for truly personalized cancer vaccines and cell therapies in a clinically actionable time frame.

NEC announced its business strategy surrounding its AI-driven drug discovery business in May 2019. This acquisition is integral for enhancing the resources and capabilities that support the development of its individualized immunotherapy pipelines. NEC will maintain its focus on drug discovery, while NEC OncoImmunity AS continues its neoantigen prediction services.

Sharing a common vision, both NEC and OncoImmunity AS firmly believe in improving individualized cancer treatments through Artificial Intelligence (AI). AI holds great promise in enabling each and every patient to receive the most appropriate medication.

"The OncoImmunity AS team are delighted to be joining the NEC Group and firmly believe that the union will realize great synergies, marrying the mutual strengths of OncoImmunity AS's and NEC's neoantigen prediction pipelines with NEC's expertise in AI, data management and security. These synergies will help strengthen NEC's individualized immunotherapy programs, whilst simultaneously positioning NEC OncoImmunity AS as the leading neoantigen prediction service provider in the field," said Dr. Richard Stratford, Chief Executive Officer and Co-founder of OncoImmunity AS.

"NEC strongly believes that healthcare based on genomics paves the way for individualized medicine. OncoImmunity AS is a recognized player in the neoantigen prediction field, and their compelling systems are expected to form valuable synergies with NEC. We are confident that this acceleration of development will provide promising new avenues that lead to better cancer treatments," said Osamu Fujikawa, Senior Vice President, NEC Corporation.

Contact:

NEC 
Seiichiro Toda         
s-toda@cj.jp.nec.com 
+81-3-3798-6511

Source: NEC Corporation
Sectors: CyberSecurity

Related Press Release

NEC and emaratech Collaborate on Biometric Smart Gates Supporting UAE Airport Operations

December 19 2025 02:06 JST

NEC Provides Vehicle Management Equipment for Autonomous Driving at Tokyo International Airport

December 15 2025 18:41 JST

NEC and AEROTHAI Elevate Air Traffic Safety with Advanced Time Sync Solutions from Adtran Oscilloquartz

December 15 2025 18:04 JST

Bank Mandiri Enhances Digital Resiliency for Financial Trading in Indonesia through Advanced Time Sync Solutions with NEC and Adtran Oscilloquartz

December 12 2025 18:59 JST

NEC and ClimateAi sign a Memorandum of Understanding (MoU) for business co-creation to enhance climate resilience across various industries

December 12 2025 17:13 JST

NEC Named to CDP's "A List" for Climate Change and Water Security for the Seventh Consecutive Year

December 11 2025 18:00 JST

NEC Presents Phase I Results for Personalized AI-Powered Oral Cancer Vaccine NECVAX-NEO1 at ESMO Immuno-Oncology Congress 2025

December 10 2025 11:00 JST

NEC Wins TIP MUST Silver Badge with Advanced Network Operating System for Open Optical Transponders

December 09 2025 12:39 JST

NEC Orchestrating Future Fund Invests in PopID, Inc. to Accelerate Global Expansion of Biometric Payment Solutions and Launch a Strategic Collaboration

December 04 2025 17:52 JST

NEC Launches AI Agent Service in Japan to Automate Procurement Negotiations Using AI

December 02 2025 22:43 JST

More Press release >>

Latest Press Release

TOYOTA GAZOO Racing Announces GR Yaris MORIZO RR
Jan 09, 2026 16:03 JST

Honda Announces New Lines of Models that Represent "Honda Sports DNA" at Tokyo Auto Salon 2026
Jan 09, 2026 14:24 JST

Honda Launches Fixed-Battery Electric Two-Wheeled Personal Commuter "Honda UC3" in Thailand and Vietnam
Jan 09, 2026 13:27 JST

Sponsorship Agreement Reached with LCR Honda; Full-Season MotoGP Entry as Pro Honda LCR
Jan 09, 2026 13:05 JST

Mazda Develops New Body Color, "Navy Blue Mica"
Jan 09, 2026 10:23 JST

Fujitsu develops digital learning platform for JAL to support self-directed learning and training management
Jan 09, 2026 10:07 JST

TOYOTA GAZOO Racing Reverting to "GAZOO Racing" to Pass on and Evolve the Making of Ever-better Cars and the Fostering of Talent
Jan 07, 2026 22:04 JST

TANAKA PRECIOUS METAL GROUP and TANAKA MIRAI Lab. Release "The TANAKA 2025" a Perfume that Expresses the Fragrance of Gold (Au)
Jan 07, 2026 22:00 JST

Toyota's European R&D center changes its name and competes in WEC with a new brand
Jan 07, 2026 21:50 JST

Hitachi Launches Expanded HMAX Solutions Accelerating Social Innovation Globally Across Industries
Jan 07, 2026 12:27 JST

Mitsubishi Motors to Celebrate "Delica Festival" with Custom Versions of Delica D:5 and Delica Mini at Tokyo Auto Salon 2026
Jan 06, 2026 16:25 JST

Mitsubishi Motors Launches the Xforce in Taiwan
Jan 06, 2026 14:42 JST

Biologics License Application for Subcutaneous Formulation of "LEQEMBI(R)" (lecanemab) for the Treatment of Early Alzheimer's Disease Accepted in China

Jan 06, 2026 10:43 JST

Alpha Growth plc: Alpha Longevity Management Ltd Expands Global Platform with Launch of Alpha Alternative Global Fund and Strengthening of Executive Leadership Team
Jan 05, 2026 16:00 JST

The Tampere city region chose Fujitsu to deliver and develop the area's ICT services
Jan 05, 2026 15:23 JST

Honda Newly Launches "Discover Honda" Content Curation Media Platform
Dec 26, 2025 17:34 JST

Mazda Selected for A List in CDP Water Security for the First Time
Dec 26, 2025 17:19 JST

Fujitsu Develops Fujitsu Kozuchi Physical AI 1.0 for Seamless Integration of Physical and Agentic AI
Dec 26, 2025 14:04 JST

Establishment of DOCOMO Innovation Fund IV, a Corporate Venture Investment Fund
Dec 26, 2025 13:53 JST

The General Incorporated Association Generative AI Japan Announces the Winners of the Japan Generative AI Award 2025
Dec 26, 2025 11:00 JST

More Latest Release >>